Mixed Ligand Cu2+ Complexes of a Model Therapeutic with Alzheimer%26apos;s Amyloid-beta Peptide and Monoamine Neurotransmitters

作者：Kenche Vijaya B; Zawisza Izabela; Masters Colin L; Bal Wojciech; Barnham Kevin J; Drew Simon C^*

来源：Inorganic Chemistry, 2013, 52(8): 4303-4318.

DOI：10.1021/ic302289r

8-Hydroxyquinolines (8HQ) have found widespread application in chemistry and biology due to their ability to complex a range of transition metal ions. The family of 2-substituted 8HQs has been proposed for use in the treatment of Alzheimer%26apos;s disease (AD). Most notably, the therapeutic PBT2 (Prana Biotechnology Ltd.) has been shown to act as an efficient metal chaperone, disaggregate metal-enriched amyloid plaques comprised of the A beta peptide, inhibit Cu/A beta redox chemistry, and reverse the AD phenotype in transgenic animal models. Yet surprisingly little is known about the molecular interactions at play. In this study, we show that the homologous ligand 2-[(dimethylamino)methyl]-8-hydroxyquinoline (HL) forms a CuL complex with a conditional (apparent) dissociation constant of 0.33 nM at pH 6.9 and is capable of forming ternary Cu2+ complexes with neurotransmitters including histamine (HA), glutamic acid (Glu), and glycine (Gly), with glutathione disulfide (GSSG), and with histidine (His) side chains of proteins and peptides including the A beta peptide. Our findings suggest a molecular basis for the strong metal chaperone activity of PBT2, its ability to attenuate Cu2+/A beta interactions, and its potential to promote neuroprotective and neuroregenerative effects.

• 出版日期2013-4-15